Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017 - Université de Lorraine Access content directly
Journal Articles Journal of Rheumatology Year : 2019

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017

Toby Smith
  • Function : Author
Michael Mansfield
  • Function : Author
Beverley Shea
  • Function : Author
Paula Williamson
  • Function : Author
Richard Loeser
  • Function : Author
Thomas Schnitzer
  • Function : Author
Tuhina Neogi
  • Function : Author
Christoph Ladel
  • Function : Author
Gurdyal Kalsi
  • Function : Author
Ulrike Kaiser
  • Function : Author
Thomas Buttel
  • Function : Author
Anne Ashford
  • Function : Author
Ali Mobasheri
Nigel Arden
  • Function : Author
Alan Tennant
  • Function : Author
Peter Tugwell

Abstract

OBJECTIVE: To assess the uptake of the OMERACT-OARSI (Outcome Measures in Rheumatology- Osteoarthritis Research Society International) core outcome set (COS) domains in hip and/or knee osteoarthritis (OA) trials. METHODS: There were 382 trials of hip and/or knee OA identified from the ClinicalTrial.gov registry from 1997 to 2017. Frequency of COS adoption was assessed by year and per 5-yearly phases. RESULTS: COS adoption decreased from 61% between 1997 and 2001 to 38% between 2012 and 2016. Pain (95%) and physical function (86%) were most consistently adopted. Patient's global assessment (48%) was the principal missing domain. CONCLUSION: Limited adoption of the COS domains indicates that further consideration to improve uptake is required.

Dates and versions

hal-02465854 , version 1 (04-02-2020)

Identifiers

Cite

Toby Smith, Michael Mansfield, Gillian Hawker, David R. Hunter, Lyn March, et al.. Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017. Journal of Rheumatology, 2019, 46 (8), pp.976-980. ⟨10.3899/jrheum.181066⟩. ⟨hal-02465854⟩
27 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More